Blueprint Medicines Corp buy Saftman
Start price
30.11.23
/
50%
€64.00
Target price
30.11.24
-
Performance (%)
10.94%
End price
31.01.24
€71.00
Summary
This prediction ended on 31.01.24 with a price of €71.00. The prediction had a final performance of 10.94%. Saftman has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Blueprint Medicines Corp | - | - | - |
| iShares Core DAX® | -0.121% | 2.507% | 16.129% |
| iShares Nasdaq 100 | 0.081% | -0.241% | 4.636% |
| iShares Nikkei 225® | -1.748% | 4.105% | 16.103% |
| iShares S&P 500 | -0.961% | -0.143% | 1.644% |
Comments by Saftman for this prediction
In the thread Blueprint Medicines Corp diskutieren
Saftman hat das Wertpapier Blueprint Medicines Corp in seinem Wikifolio Langfristige Aufwärtstrends gekauft.